Si-Bone (SIBN) EBITDA (2017 - 2026)

Si-Bone has reported EBITDA for 10 years, with the latest figure at -$4.8 million in Q2 2026.

• On a quarterly basis, EBITDA rose 31.38% year-over-year to -$4.8 million in Q2 2026; TTM through Jun 2026 was -$17.7 million, a 35.73% increase from a year earlier, with the FY2025 full-year figure at -$22.3 million, up 36.65% from the prior year.
• EBITDA was -$4.8 million for Q2 2026 at Si-Bone, up from -$5.1 million in the prior quarter.
• The five-year high for EBITDA was -$2.5 million in Q4 2025, with the low at -$17.9 million in Q2 2022.
• Average EBITDA over 5 years is -$9.7 million, with a median of -$10.6 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: EBITDA plunged 45.73% in 2022, then surged 56.07% in 2024.
• Over 5 years, EBITDA stood at -$11.3 million in 2022, then decreased by 10.73% to -$12.5 million in 2023, then soared by 56.07% to -$5.5 million in 2024, then jumped by 55.17% to -$2.5 million in 2025, then tumbled by 95.13% to -$4.8 million in 2026.
• The last three EBITDA figures came in at -$4.8 million (Q2 2026), -$5.1 million (Q1 2026), and -$2.5 million (Q4 2025), per Business Quant data.